Dr. Sandy Tretbar introduces CAR Finder Technology and shares practical strategies to improve mRNA-based CAR T cell screening and selection.

Developing effective CAR T cell therapies hinges on identifying the most potent chimeric antigen receptor (CAR) molecules. In this webinar, Dr. Sandy Tretbar will discuss why rapid and comprehensive screening of CARs is essential to advancing successful treatments for various diseases. The session will explore the latest advancements in mRNA-based CAR T cell generation and address the common hurdles researchers face in identifying the ideal CAR for therapeutic use.

Attendees will gain insights into the challenges of CAR selection and how emerging technologies are revolutionizing this process. A highlight of the webinar will be the introduction of the innovative CAR Finder Technology—a powerful tool designed to streamline and enhance the screening of CAR molecules, helping scientists pinpoint the most promising candidates for clinical development.

Key Topics Include:

  • Generation of mRNA-based CAR T Cell Therapies
  • Challenges with finding the perfect CAR
  • The new CAR Finder Technology to screen for best CARs

Presenters

Sandy Tretbar, ;PhD

Sandy Tretbar, PhD

Group Leader
Cell and Gene Therapy Development
Fraunhofer Institute for Cell Therapy and Immunology

Dr. Sandy Tretbar is a Molecular Biology and RNA Biochemist by training who spent her PhD and postdoc time in Germany and the US. After her second Postdoc in the immunology field, she joined the Fraunhofer IZI in 2018 as Research Associate and advanced as Group Leader in 2021. Now, she combines her long-standing RNA research experience with cell therapy development in immuno-oncology to investigate mRNA-based cell and gene therapies for the treatment of cancer and various other diseases.
Watch Webinar

Production Partner

Lonza Bioscience

Lonza is one of the world’s largest contract development and manufacturing organizations (CDMOs) dedicated to serving the healthcare industry. Working across five continents, our colleagues work alongside pharma and biotech companies to turn their breakthrough innovations into viable therapies. We support our customers in bringing life-saving and life-enhancing treatments to patients worldwide with a combination of cutting-edge science, smart technology and lean manufacturing.

VIEW PROFILE
Lonza Bioscience

Additional Content From Lonza Bioscience

Additional Content From Scientist.com

Related Content